Is it time to stage prostate cancer using molecular imaging?
Prostate cancer is one of the most common cancers in men. After the diagnosis is made, staging should be undertaken with imaging methods in order to plan the treatment and predict the prognosis. Parallel to technological developments in recent years, new imaging methods have entered into cl...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ali İhsan Taşçı
2022-06-01
|
| Series: | Yeni Üroloji Dergisi |
| Online Access: | https://dergipark.org.tr/en/pub/yud/issue/70180/1035767 |
| _version_ | 1797919831929913344 |
|---|---|
| author | Özer Güzel Fazlı Polat Ali Atan |
| author_facet | Özer Güzel Fazlı Polat Ali Atan |
| author_sort | Özer Güzel |
| collection | DOAJ |
| description | Prostate cancer is one of the most common cancers in men. After the diagnosis is made, staging should be undertaken with imaging methods in order to plan the treatment and predict the prognosis. Parallel to technological developments in recent years, new imaging methods have entered into clinical use. Among these methods, prostate-specific membrane antigen (PSMA) positron emission tomography (PET) imaging has come to the fore since it provides anatomical and functional imaging and has many advantages in tumor (T), nodal (N) and metastatic (M) staging. This review discusses the current status of the PSMA- PET method in prostate cancer staging. Keywords: prostate cancer, staging, positron emission tomography |
| first_indexed | 2024-04-10T13:51:41Z |
| format | Article |
| id | doaj.art-11aa7bc15bcd4f87974c135301e0e1be |
| institution | Directory Open Access Journal |
| issn | 1305-2489 2687-1955 |
| language | English |
| last_indexed | 2024-04-10T13:51:41Z |
| publishDate | 2022-06-01 |
| publisher | Ali İhsan Taşçı |
| record_format | Article |
| series | Yeni Üroloji Dergisi |
| spelling | doaj.art-11aa7bc15bcd4f87974c135301e0e1be2023-02-15T16:10:39ZengAli İhsan TaşçıYeni Üroloji Dergisi1305-24892687-19552022-06-0117210911510.33719/yud.2022;17-2-1035767Is it time to stage prostate cancer using molecular imaging?Özer Güzelhttps://orcid.org/0000-0003-4647-4706Fazlı Polathttps://orcid.org/0000-0002-1219-5082Ali Atanhttps://orcid.org/0000-0002-7114-068X Prostate cancer is one of the most common cancers in men. After the diagnosis is made, staging should be undertaken with imaging methods in order to plan the treatment and predict the prognosis. Parallel to technological developments in recent years, new imaging methods have entered into clinical use. Among these methods, prostate-specific membrane antigen (PSMA) positron emission tomography (PET) imaging has come to the fore since it provides anatomical and functional imaging and has many advantages in tumor (T), nodal (N) and metastatic (M) staging. This review discusses the current status of the PSMA- PET method in prostate cancer staging. Keywords: prostate cancer, staging, positron emission tomographyhttps://dergipark.org.tr/en/pub/yud/issue/70180/1035767 |
| spellingShingle | Özer Güzel Fazlı Polat Ali Atan Is it time to stage prostate cancer using molecular imaging? Yeni Üroloji Dergisi |
| title | Is it time to stage prostate cancer using molecular imaging? |
| title_full | Is it time to stage prostate cancer using molecular imaging? |
| title_fullStr | Is it time to stage prostate cancer using molecular imaging? |
| title_full_unstemmed | Is it time to stage prostate cancer using molecular imaging? |
| title_short | Is it time to stage prostate cancer using molecular imaging? |
| title_sort | is it time to stage prostate cancer using molecular imaging |
| url | https://dergipark.org.tr/en/pub/yud/issue/70180/1035767 |
| work_keys_str_mv | AT ozerguzel isittimetostageprostatecancerusingmolecularimaging AT fazlıpolat isittimetostageprostatecancerusingmolecularimaging AT aliatan isittimetostageprostatecancerusingmolecularimaging |